Treatment Strategies in Endogenous Fungal Endophthalmitis - Top-Institutions - MDSpire

Treatment Strategies in Endogenous Fungal Endophthalmitis

Management of endogenous fungal endophthalmitis is complex, with wide variation in treatment strategies. Systemic markers of disease appear to influence the choice of initial therapy more than ocular findings. Although no definitive evidence favors IV over oral systemic therapy, a comprehensive, multidisciplinary approach that considers ocular involvement is essential to optimize patient outcomes in EFE.

  • By

  • Arthi Venkat, MD, MS

  • Eleanor M. Burton, MD

  • January 1, 2026

  • 7 min

Share

Top Institutions in Ophthalmology

Brief introduction explaining scope and methodology.

  • #1

    Massachusetts Eye and Ear Infirmary
    Massachusetts Eye and Ear Infirmary

    Boston, MA

    Key Differentiators

    • Ophthalmology
    • Infectious Diseases

  • #2

    Bascom Palmer Eye Institute, University of Miami
    Bascom Palmer Eye Institute, University of Miami

    Miami, FL

    Key Differentiators

    • Ophthalmology
    • Infectious Diseases

  • #3

    Johns Hopkins Wilmer Eye Institute
    Johns Hopkins Wilmer Eye Institute

    Baltimore, MD

    Key Differentiators

    • Ophthalmology
    • Infectious Diseases

  • #4

    University of California, San Francisco (UCSF) Medical Center
    University of California, San Francisco (UCSF) Medical Center

    San Francisco, CA

    Key Differentiators

    • Ophthalmology
    • Infectious Diseases

  • #5

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Ophthalmology
    • Infectious Diseases

Original Source(s)

Treatment Strategies in Endogenous Fungal Endophthalmitis

  • by Arthi Venkat, MD, MS, Eleanor M. Burton, MD

  • January 1, 2026

Related Content

Surgery, Science, and Inclusion

Upfront: Monthly reflection by Editor in Chief Diana V. Do, MD.

Uveitis Coding Considerations

Targeting IL-6 in the Treatment of Uveitic Macular Edema

Vamikibart shows promise as a new treatment for uveitic macular edema, improving vision and safety compared to existing steroids. Source: Dr. Rahul Khurana.